124 related articles for article (PubMed ID: 6268760)
1. Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.
Perry RH; Dockray GJ; Dimaline R; Perry EK; Blessed G; Tomlinson BE
J Neurol Sci; 1981 Sep; 51(3):465-72. PubMed ID: 6268760
[TBL] [Abstract][Full Text] [Related]
2. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
Yaksh TL; Abay EO; Go VL
Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
[TBL] [Abstract][Full Text] [Related]
4. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin (CCK) and vasoactive intestinal peptide (VIP) in the cerebral cortex of the non-hibernating and hibernating golden mantled ground squirrel.
Bauman WA; Meryn S; Florant GL
Comp Biochem Physiol A Comp Physiol; 1988; 91(1):179-81. PubMed ID: 2904329
[TBL] [Abstract][Full Text] [Related]
6. Co-existence of vasoactive intestinal polypeptide (VIP)- and cholecystokinin (CCK)-like immunoreactivities in thalamocortical neuron in the ventrolateral nucleus of the rat.
Ogawa R; Itoh K; Kaneko T; Mizuno N
Brain Res; 1989 Jun; 490(1):152-6. PubMed ID: 2758323
[TBL] [Abstract][Full Text] [Related]
7. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
Wang JY; Yaksh TL; Go VL
Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
[TBL] [Abstract][Full Text] [Related]
8. Brain cholecystokinin and vasoactive intestinal polypeptide: immunoreactivity in rabbits with hepatic coma.
Meryn S; Bauman WA; Pappas SC; Ferenci P; Jones EA
Liver; 1986 Oct; 6(5):281-5. PubMed ID: 3784782
[TBL] [Abstract][Full Text] [Related]
9. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.
Biggins JA; Perry EK; McDermott JR; Smith AI; Perry RH; Edwardson JA
J Neurol Sci; 1983 Jan; 58(1):117-22. PubMed ID: 6405015
[TBL] [Abstract][Full Text] [Related]
10. CCK receptors and human neurological disease.
Hays SE; Paul SM
Life Sci; 1982 Jul; 31(4):319-22. PubMed ID: 6292647
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
Mazurek MF; Beal MF
Neurology; 1991 May; 41(5):716-9. PubMed ID: 1674117
[TBL] [Abstract][Full Text] [Related]
12. Preferential inputs from cholecystokinin-positive neurons to the somatic compartment of parvalbumin-expressing neurons in the mouse primary somatosensory cortex.
Hioki H; Sohn J; Nakamura H; Okamoto S; Hwang J; Ishida Y; Takahashi M; Kameda H
Brain Res; 2018 Sep; 1695():18-30. PubMed ID: 29792869
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa.
Harty RF; Pearson PH; Solomon TE; McGuigan JE
Regul Pept; 1991 Oct; 36(1):141-50. PubMed ID: 1796180
[TBL] [Abstract][Full Text] [Related]
14. Development of vasoactive intestinal polypeptide (VIP) containing neurones in the rat brain.
Emson PC; Gilbert RF; Loren I; Fahrenkrug J; Sundler F; Schaffalitzky de Muckadell OB
Brain Res; 1979 Nov; 177(3):437-44. PubMed ID: 387178
[TBL] [Abstract][Full Text] [Related]
15. Additional observations on cholecystokinin and the vasoactive intestinal polypeptide.
Mutt V
Peptides; 1981; 2 Suppl 2():209-14. PubMed ID: 6283492
[TBL] [Abstract][Full Text] [Related]
16. The development of motilin, cholecystokinin and vasoactive intestinal peptide immunoreactivity in the forebrain and hindbrain of the rat, as determined by radioimmunoassay.
Beinfeld MC; Korchak DM; Nilaver G; O'Dorisio TM
Brain Res; 1983 Oct; 312(1):146-50. PubMed ID: 6652504
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex.
Allard LR; Beinfeld MC
Neuropeptides; 1986 Oct; 8(3):287-93. PubMed ID: 3785588
[TBL] [Abstract][Full Text] [Related]
18. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
[TBL] [Abstract][Full Text] [Related]
19. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
Ryan JP; Ryave S
Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
[TBL] [Abstract][Full Text] [Related]
20. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.
Hang CH; Shi JX; Li JS; Wu W; Li WQ; Yin HX
World J Gastroenterol; 2004 Mar; 10(6):875-80. PubMed ID: 15040036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
